Danske Bank’s Zimmer Biomet ZBH Stock Holding History

Danske Bank’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11.6M	Sell	128,617 -5,100	-4%	-$468K	0.03%	403
2025 Q4	$12M	Buy	133,717 +7,400	+6%	+$702K	0.03%	408
2025 Q3	$12.4M	Buy	126,317 +2,300	+2%	+$228K	0.03%	381
2025 Q2	$11.3M	Buy	124,017 +8,604	+7%	+$832K	0.03%	413
2025 Q1	$13.1M	Sell	115,413 -19,224	-14%	-$2.06M	0.04%	347
2024 Q4	$14.2M	Buy	134,637 +30,524	+29%	+$3.28M	0.04%	345
2024 Q3	$11.2M	Sell	104,113 -31,069	-23%	-$3.39M	0.04%	367
2024 Q2	$14.7M	Buy	135,182 +27,469	+26%	+$3.24M	0.05%	294
2024 Q1	$14.2M	Buy	+107,713	New	+$13.5M	0.04%	351

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Danske Bank's ZBH Position: Q1 2026 in Review

Danske Bank reduced its Zimmer Biomet (ZBH) stake by 3.8% in Q1 2026, selling an estimated $468K and leaving 128,617 shares worth $11.6M. The position accounts for 0.03% of the portfolio, ranked #403.

Danske Bank first reported a position in ZBH in Q1 2024 and has held it in 9 quarters since. The position peaked at $14.7M in Q2 2024. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

Danske Bank held 128,617 shares of Zimmer Biomet worth $11.6M as of Q1 2026.
Danske Bank sold 5,100 Zimmer Biomet shares in Q1 2026, an estimated $468K.
Zimmer Biomet made up 0.03% of Danske Bank's portfolio in Q1 2026, its #403 holding.
Danske Bank first reported a position in Zimmer Biomet in Q1 2024 and has held it in 9 quarters since.
Danske Bank's Zimmer Biomet position peaked at $14.7M in Q2 2024.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Danske Bank's 13F filing for Q1 2026, filed 12 May 2026.